Letrozole in fertility treatment

Ugeskr Laeger. 2023 Oct 9;185(41):V05230315.
[Article in Danish]

Abstract

This review describes the current evidence regarding the putative indications of letrozole (LTZ) in fertility treatment. Prior to intrauterine insemination, LTZ is recommended in women with normogonadotrophic oligo-anovulation. In ovulatory women, LTZ is equal to clomiphene and may be used instead of exogenous gonadotrophin. LTZ may be used as co-treatment in poor responders prior to in vitro fertilization/intracytoplasmic sperm injection. In addition, LTZ prior to frozen-thawed embryo transfer is increasingly used in women with normogonadotrophic oligo-anovulation.

Publication types

  • Review
  • English Abstract

MeSH terms

  • Anovulation* / therapy
  • Clomiphene / therapeutic use
  • Female
  • Fertility Agents, Female
  • Humans
  • Letrozole / therapeutic use
  • Male
  • Semen

Substances

  • Letrozole
  • Fertility Agents, Female
  • Clomiphene